Literature DB >> 1178015

Letter: Intrahepatic portasystemic shunting in cirrhotic patients.

G Gross, C V Perrier.   

Abstract

Entities:  

Mesh：

Year:  1975        PMID： 1178015     DOI： 10.1056/NEJM197511132932017

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Source of raised serum estrogens in male rats with portal bypass.

Authors:  G C Farrell; A Koltai; M Murray
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 2.  Pathologic aspects of cirrhosis. A review.

Authors:  H Popper
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

3.  Mesocaval and distal splenorenal shunts: effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathy.

Authors:  R Herz; H J Halbfass; M Rössle; D Waldmann; W Gerok
Journal:  Klin Wochenschr       Date:  1985-05-02

4.  Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver.

Authors:  P J Pentikäinen; P J Neuvonen; K G Jostell
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

Review 5.  Propranolol disposition in chronic liver disease: a physiological approach.

Authors:  R A Branch; D G Shand
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Effects of intra- and extrahepatic portal systemic shunts on insulin metabolism.

Authors:  K Ohnishi; A Mishima; M Takashi; S Tsuchiya; S Iida; S Iwama; N Goto; K Kono; Y Nakajima; N Suzuki; H Musha; K Okuda
Journal:  Dig Dis Sci       Date:  1983-03       Impact factor: 3.199

Review 7.  Limitations of percutaneous transhepatic cholangioscopy in the removal of complicated biliary calculi.

Authors:  K S Jeng; H J Chiang; S C Shih
Journal:  World J Surg       Date:  1989 Sep-Oct       Impact factor: 3.352
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.